3D打印羟基磷灰石-脱钙骨基质支架用于脊柱融合的临床前安全性研究
结果显示,HA-DBM支架在术后第2天和第5天融合床软组织水肿显著少于rhBMP-2组,且与胶原海绵对照组相当;术后第2天rhBMP-2组血清TNF-α和MCP-1显著升高,而HA-DBM组未升高。结论认为3D打印HA-DBM复合材料相对rhBMP-2可显著减轻宿主炎症反应。
要点
- HA-DBM支架在术后2天和5天融合床软组织水肿显著低于rhBMP-2组。
- HA-DBM组各时间点软组织水肿水平与ACS对照组相当。
- 术后2天rhBMP-2组血清TNF-α和MCP-1显著升高,HA-DBM组未升高。
核心结论
- 在临床前脊柱融合模型中,3D打印HA-DBM复合材料相对rhBMP-2可显著减轻宿主炎症反应。
研究设计与样本
- 植入物分为I型可吸收胶原海绵(ACS)单独组、10 μg rhBMP-2/ACS组和3DP HA-DBM复合支架组。
- 采用磁共振成像评估宿主炎症反应,用酶联免疫吸附试验评估局部和循环细胞因子表达水平,每个时间点N=5。
主要发现
- 术后2天和5天,HA-DBM支架组融合床软组织水肿在MRI量化上显著少于rhBMP-2组。
- 各术后时间点HA-DBM组软组织水肿水平与ACS对照组相当。
- 术后2天,rhBMP-2组血清肿瘤坏死因子-α和巨噬细胞趋化蛋白-1相对ACS对照组显著升高,而HA-DBM组这些细胞因子未升高。
临床怎么用
- 在脊柱融合的临床前评估中,3D打印HA-DBM复合材料可能作为rhBMP-2的替代选择以降低炎症反应。
- 需关注rhBMP-2相关局部软组织水肿和全身细胞因子升高的风险,HA-DBM在此方面表现更接近ACS对照。
局限性
- 研究为临床前大鼠模型,样本量每组20只,结论外推至临床需谨慎。
- 原文未报告长期融合效果、骨形成质量及更远期安全性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Prospective, randomized, controlled preclinical study. OBJECTIVE: The objective of this study was to compare the host inflammatory response of our previously described hyperelastic, 3D-printed (3DP) hydroxyapatite (HA)-demineralized bone matrix (DBM) composite scaffold to the response elicited with the use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in a preclinical rat posterolateral lumbar fusion model. SUMMARY OF BACKGROUND DATA: Our group previously found that this 3D-printed HA-DBM composite material shows promise as a bone graft substitute in a preclinical rodent model, but its safety profile had yet to be assessed. METHODS: Sixty female Sprague-Dawley rats underwent bilateral posterolateral intertransverse lumbar spinal fusion using with the following implants: 1) type I absorbable collagen sponge (ACS) alone; 2) 10 μg rhBMP-2/ACS; or 3) the 3DP HA-DBM composite scaffold (n = 20). The host inflammatory response was assessed using magnetic resonance imaging, while the local and circulating cytokine expression levels were evaluated by enzyme-linked immunosorbent assays at subsequent postoperative time points (N = 5/time point). RESULTS: At both 2 and 5 days postoperatively, treatment with the HA-DBM scaffold produced significantly less soft tissue edema at the fusion bed site relative to rhBMP-2-treated animals as quantified on magnetic resonance imaging. At every postoperative time point evaluated, the level of soft tissue edema in HA-DBM-treated animals was comparable to that of the ACS control group. At 2 days postoperatively, serum concentrations of tumor necrosis factor-α and macrophage chemoattractant protein-1 were significantly elevated in the rhBMP-2 treatment group relative to ACS controls, whereas these cytokines were not elevated in the HA-DBM-treated animals. CONCLUSION: The 3D-printed HA-DBM composite induces a significantly reduced host inflammatory response in a preclinical spinal fusion model relative to rhBMP-2.Level of Evidence: N/A.
引用
- Plantz M, Lyons J, Yamaguchi JT, et al. Preclinical Safety of a 3D-Printed Hydroxyapatite-Demineralized Bone Matrix Scaffold for Spinal Fusion. Spine (Phila Pa 1976). 2022. PMID: 34115714. doi:10.1097/BRS.0000000000004142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。